
Top news of the week in cancer drug development.
Top stories of the week on Specialty Pharmacy Times.
Immunosuppressive drug linked to central nervous system lymphoma in solid organ transplant patients.
Rhabdomyosarcoma is the most common soft tissue sarcoma in children.
Study suggests superior efficacy from older PsA drugs.
GAO made recommendations for safeguards to prevent enrollees from having Medicaid and exchange coverage at the same time.
A specialty mail-order pharmacy that filled prescriptions for Valeant has closed amid reports of improper behavior.
Ligand-guided protein cages kill more than 70 percent of lung cancer cells during testing.
Study may lead to enhanced efficacy of breast cancer drugs.
Strategy reduces cost without compromising RA symptom control.
Blood test offers insight into how well a drug is working during the course of cancer treatment.
A woman's hormonal status may resume balance.
Pharmacists may be able to reduce hospital readmissions by calling discharged patients to check in about their medications.
T-VEC is a first-in-class immunotherapy for unresectable cutaneous, subcutaneous, and nodal lesions in advanced melanoma.
Cheryl Allen, RPh, BSPharm, MBA, vice president of Industry Relations at Diplomat, discusses the services offered by Diplomat's HUB EnvoyHealth program.
Malaria protein is able to attack more than 90 percent of all tumor types.
Rite Aid will retain its brand name for the immediate future.
Waist circumference in middle age associated with increased bowel cancer risk.
Strategic allicance partners share knowledge and increase the visibility of the participating pharmacy organization.
Mischaracterization of specialty pharmacy rampant amid growing controversy regarding specialty drug pricing.
Experts discuss issues faced by patients starting an HIV therapy regimen.
Non-Hispanic whites more likely to be diagnosed with less advanced stages of breast cancer.
Twice-daily niacin pill for 12-months reduced the incidence of new non-melanoma skin cancers.
A pharmacist sentenced to 4 years in prison for charges related to the sale of counterfeit medications has been released from prison early.
Clonogenic stem cells show heightened self-renewal and differentiation capacities in multiple myeloma.
Tom Roark, PAHM, director of contract management at Diplomat, discusses the value contract management in specialty pharmacy operations.
Accelerated partial breast irradiation reduces therapy into just 5 days.
Treatment used in combination with fluorouracil and leucovorin for patients with metastatic pancreatic cancer.
Treatment shows significant improvement in progression-free survival in patients with unresectable or metastatic liposarcoma or leiomyosarcoma.
Patients with Crohn's disease taking angiotensin converting enzyme inhibitors have significantly higher rate of hospitalizations.